Julie Gralow/citycancerchallenge.org
Jun 8, 2025, 05:57
SWOG’s Pragmatica-Lung Study as Model for Patient-Centered Trial Design – Julie Gralow
Julie Gralow, Chief Medical Officer (CMO) of the American Society of Clinical Oncology, shared a post on X:
“The SWOG Pragmatica-Lung study is a model for pragmatic, efficient, patient-centered trial design.”
Read “SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC”.
More posts featuring Julie Gralow on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 02:49
Aug 21, 2025, 23:33
Aug 21, 2025, 20:00
Aug 21, 2025, 15:59